Plus, news about Pyxis, Epitopea and Genevant: Idorsia’s deal for blood pressure drug hits snag: The Swiss company said negotiations…
Author: Ayisha Sharma
In a major reset to round off the year, Aadi Bioscience is divesting its only marketed product and in-licensing a…
Read more about this post on endpoints
Boundless Bio is trimming its oncology pipeline in the wake of disappointing cancer data and switching up its leadership just…
This year’s San Antonio Breast Cancer Conference yielded major clinical updates on some of the hottest areas of oncology, from…
Gilead Sciences has tapped Sanofi’s Dietmar Berger as its next chief medical officer in a bid to shake up its…
Candel Therapeutics’ viral immunotherapy candidate passed a late-stage test in certain patients with prostate cancer, sending its share price {$CADL}…
Johnson & Johnson and Legend Biotech say their CAR-T therapy Carvykti has the potential to remove all traces of disease…
AstraZeneca and Daiichi Sankyo have unveiled new data on their TROP2-directed ADC in pretreated lung cancer patients with EGFR-mutated disease,…
Merck’s top medical exec said its recent bet on a VEGF bispecific antibody — one of the hottest areas in…